OVID THERAPEUTICS INC's ticker is OVID and the CUSIP is 690469101. A total of 65 filers reported holding OVID THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,600 | +17.1% | 2,500,000 | 0.0% | 0.41% | +62.2% |
| Q2 2023 | $8,200 | +27.1% | 2,500,000 | 0.0% | 0.25% | -33.7% |
| Q1 2023 | $6,450 | +38.7% | 2,500,000 | 0.0% | 0.38% | +47.3% |
| Q4 2022 | $4,650 | -99.9% | 2,500,000 | 0.0% | 0.26% | +32.7% |
| Q3 2022 | $4,600,000 | -14.4% | 2,500,000 | 0.0% | 0.20% | -31.7% |
| Q2 2022 | $5,375,000 | -31.5% | 2,500,000 | 0.0% | 0.29% | -12.8% |
| Q1 2022 | $7,850,000 | -2.2% | 2,500,000 | 0.0% | 0.33% | +50.9% |
| Q4 2021 | $8,025,000 | -4.5% | 2,500,000 | 0.0% | 0.22% | +16.0% |
| Q3 2021 | $8,400,000 | -14.1% | 2,500,000 | 0.0% | 0.19% | -5.1% |
| Q2 2021 | $9,775,000 | -2.7% | 2,500,000 | 0.0% | 0.20% | +11.2% |
| Q1 2021 | $10,050,000 | +74.0% | 2,500,000 | 0.0% | 0.18% | +43.5% |
| Q4 2020 | $5,775,000 | -59.8% | 2,500,000 | 0.0% | 0.12% | -64.4% |
| Q3 2020 | $14,350,000 | – | 2,500,000 | – | 0.35% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TLS Advisors LLC | 1,319,679 | $4,329 | 18.57% |
| Madison Avenue Partners, LP | 3,307,605 | $10,848,943 | 2.37% |
| CHI Advisors LLC | 864,822 | $2,836,616 | 0.86% |
| Rubric Capital Management LP | 5,445,910 | $17,862,585 | 0.76% |
| BVF INC/IL | 6,851,051 | $22,471,447 | 0.63% |
| EcoR1 Capital, LLC | 6,117,400 | $20,065,072 | 0.49% |
| Artal Group S.A. | 2,500,000 | $8,200 | 0.25% |
| Tejara Capital Ltd | 112,591 | $369,298 | 0.18% |
| DCF Advisers, LLC | 64,764 | $212,426 | 0.11% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 801,152 | $2,627,779 | 0.06% |